Predicting COVID-19 infection risk in people who are immunocompromised by antibody testing.

MLA

Wijaya, Ratna, et al. “Predicting COVID-19 Infection Risk in People Who Are Immunocompromised by Antibody Testing.” Lancet (London, England), vol. 402, no. 10396, July 2023, pp. 99–102. EBSCOhost, https://doi.org/10.1016/S0140-6736(23)01180-7.

APA

Wijaya, R., Johnson, M., Campbell, N., Stuart, B., Kelly, A., Tipler, N., Menne, T., Ahearne, M. J., Willimott, V., Al-Naeeb, A. B., Fox, C. P., Collins, G. P., O’Callaghan, A., Davies, A. J., Goldblatt, D., & Lim, S. H. (2023). Predicting COVID-19 infection risk in people who are immunocompromised by antibody testing. Lancet (London, England), 402(10396), 99–102. https://doi.org/10.1016/S0140-6736(23)01180-7

Chicago

Wijaya, Ratna, Marina Johnson, Nicola Campbell, Beth Stuart, Adam Kelly, Nicole Tipler, Tobias Menne, et al. 2023. “Predicting COVID-19 Infection Risk in People Who Are Immunocompromised by Antibody Testing.” Lancet (London, England) 402 (10396): 99–102. doi:10.1016/S0140-6736(23)01180-7.